Cargando…
Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases
Copeptin is the carboxyl-terminus of the arginine vasopressin (AVP) precursor peptide. The main physiological functions of AVP are fluid and osmotic balance, cardiovascular homeostasis, and regulation of endocrine stress response. Copeptin, which is released in an equimolar mode with AVP from the ne...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289206/ https://www.ncbi.nlm.nih.gov/pubmed/35859595 http://dx.doi.org/10.3389/fcvm.2022.901990 |
_version_ | 1784748612663640064 |
---|---|
author | Mu, Danni Cheng, Jin Qiu, Ling Cheng, Xinqi |
author_facet | Mu, Danni Cheng, Jin Qiu, Ling Cheng, Xinqi |
author_sort | Mu, Danni |
collection | PubMed |
description | Copeptin is the carboxyl-terminus of the arginine vasopressin (AVP) precursor peptide. The main physiological functions of AVP are fluid and osmotic balance, cardiovascular homeostasis, and regulation of endocrine stress response. Copeptin, which is released in an equimolar mode with AVP from the neurohypophysis, has emerged as a stable and simple-to-measure surrogate marker of AVP and has displayed enormous potential in clinical practice. Cardiovascular disease (CVD) is currently recognized as a primary threat to the health of the population worldwide, and thus, rapid and effective approaches to identify individuals that are at high risk of, or have already developed CVD are required. Copeptin is a diagnostic and prognostic biomarker in CVD, including the rapid rule-out of acute myocardial infarction (AMI), mortality prediction in heart failure (HF), and stroke. This review summarizes and discusses the value of copeptin in the diagnosis, discrimination, and prognosis of CVD (AMI, HF, and stroke), as well as the caveats and prospects for the application of this potential biomarker. |
format | Online Article Text |
id | pubmed-9289206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92892062022-07-19 Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases Mu, Danni Cheng, Jin Qiu, Ling Cheng, Xinqi Front Cardiovasc Med Cardiovascular Medicine Copeptin is the carboxyl-terminus of the arginine vasopressin (AVP) precursor peptide. The main physiological functions of AVP are fluid and osmotic balance, cardiovascular homeostasis, and regulation of endocrine stress response. Copeptin, which is released in an equimolar mode with AVP from the neurohypophysis, has emerged as a stable and simple-to-measure surrogate marker of AVP and has displayed enormous potential in clinical practice. Cardiovascular disease (CVD) is currently recognized as a primary threat to the health of the population worldwide, and thus, rapid and effective approaches to identify individuals that are at high risk of, or have already developed CVD are required. Copeptin is a diagnostic and prognostic biomarker in CVD, including the rapid rule-out of acute myocardial infarction (AMI), mortality prediction in heart failure (HF), and stroke. This review summarizes and discusses the value of copeptin in the diagnosis, discrimination, and prognosis of CVD (AMI, HF, and stroke), as well as the caveats and prospects for the application of this potential biomarker. Frontiers Media S.A. 2022-07-04 /pmc/articles/PMC9289206/ /pubmed/35859595 http://dx.doi.org/10.3389/fcvm.2022.901990 Text en Copyright © 2022 Mu, Cheng, Qiu and Cheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Mu, Danni Cheng, Jin Qiu, Ling Cheng, Xinqi Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases |
title | Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases |
title_full | Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases |
title_fullStr | Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases |
title_full_unstemmed | Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases |
title_short | Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases |
title_sort | copeptin as a diagnostic and prognostic biomarker in cardiovascular diseases |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289206/ https://www.ncbi.nlm.nih.gov/pubmed/35859595 http://dx.doi.org/10.3389/fcvm.2022.901990 |
work_keys_str_mv | AT mudanni copeptinasadiagnosticandprognosticbiomarkerincardiovasculardiseases AT chengjin copeptinasadiagnosticandprognosticbiomarkerincardiovasculardiseases AT qiuling copeptinasadiagnosticandprognosticbiomarkerincardiovasculardiseases AT chengxinqi copeptinasadiagnosticandprognosticbiomarkerincardiovasculardiseases |